Publications
114
Citations
8,164
Est. group size
~2
Recurring co-author estimate
Active years
33
Publishing since 1994
Yuri Pekarsky's research focuses on the molecular biology of chronic lymphocytic leukemia (CLL), a type of blood cancer, with particular attention to small non-coding RNA molecules such as microRNAs and tRNA-derived fragments that regulate gene expression and contribute to cancer development. Work also examines genetic deletions (microdeletions) and endogenous retrovirus activity linked to CLL, as well as broader mechanisms of tumor immune evasion. This research is largely laboratory-based molecular and genetic study aimed at understanding cancer biology and identifying potential biomarkers and therapeutic targets.
Publication output has been uneven over the last decade, with gaps in some years (2020-2021, 2024-2025) followed by a notable spike in 2022-2023, suggesting bursty rather than steady output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Avoidance of immune mediated tumor rejection by cancer cells
Advances in Biological Regulation · 2026
- Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia
Proceedings of the National Academy of Sciences · 2023
- Supplementary Tables 1 - 2 from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Supplementary Figure 1 from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Data from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Data from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Supplementary Figure 1 from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Supplementary Figure Legend from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Supplementary Tables 1 - 2 from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- Supplementary Figure Legend from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by <i>miR-29</i> and <i>miR-181</i>
2023
- tRNA-derived fragments (tRFs) in cancer
Journal of Cell Communication and Signaling · 2022
- A large fraction of trisomy 12, 17p <sup>−</sup> , and 11q <sup>−</sup> CLL cases carry unidentified microdeletions of <i>miR-15a/16-1</i>
Proceedings of the National Academy of Sciences · 2022
- miR-15/16 in human malignancies
Elsevier eBooks · 2022
- Noncoding RNA genes in cancer pathogenesis
Advances in Biological Regulation · 2018
- BCL2 and miR-15/16: from gene discovery to treatment
Cell Death and Differentiation · 2017
- Proceedings of the National Academy of Sciences×7
- Blood×3
- Advances in Biological Regulation×2
- Elsevier eBooks×2
- Cell Death and Differentiation×1
- Veronica Balatti
Medicine · The Ohio State University
- Xiaoli Zhang
Medicine · The Ohio State University
- Ethan Hopping
Medicine · The Ohio State University
- Altan Turkoglu
Medicine · The Ohio State University
- Huabao Wang
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile